Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Vincristine sulphate liposomes

EU orphan designation number: EU/3/08/555   
Active ingredient: Vincristine sulphate liposomes
Indication: Treatment of acute lymphoblastic leukaemia
Sponsor: NDA Regulatory Science Ltd
Prime House, Challenge Court, Barnett Wood Lane, Leatherhead, Surrey KT22 7DE, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
10/07/2008 Centralised Orphan - Designation EMEA/OD/002/08 (2008)3595 of 08/07/2008
15/04/2009 Centralised Orphan - Transfer of orphan designation EMEA/OD/002/08/T/01 (2009)2907 of 08/04/2009
09/11/2010 Other procedure EMA/581201/2010
18/05/2011 Centralised Orphan - Transfer of orphan designation EMEA/OD/002/08/T/02 (2011)3481 of 13/05/2011